Will Statera Biopharma Inc (STAB) Stay at the Bottom of the Healthcare Sector?

Monday, May 02, 2022 01:53 PM | InvestorsObserver Analysts

Mentioned in this article

Will Statera Biopharma Inc (STAB) Stay at the Bottom of the Healthcare Sector?

Statera Biopharma Inc (STAB) is near the bottom in its sector according to InvestorsObserver. STAB gets an overall rating of 32. That means it scores higher than 32% of stocks. Statera Biopharma Inc gets a 4 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

STAB has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on STAB!

See Full STAB Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 32 means the stock is more attractive than 32 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Statera Biopharma Inc Stock Today?

Statera Biopharma Inc (STAB) stock is trading at $0.29 as of 1:53 PM on Monday, May 2, a loss of -$0.05, or -13.72% from the previous closing price of $0.33. The stock has traded between $0.28 and $0.32 so far today. Volume today is less active than usual. So far 5,384,903 shares have traded compared to average volume of 14,485,160 shares. Click Here to get the full Stock Report for Statera Biopharma Inc stock.